NASDAQ

Agios Reports Third Quarter 2017 Financial Results

IDHIFA® Approval for IDH2m R/R AML Validates Precision Medicine Approach; Ivosidenib NDA Submission for ...

Agios Reports Third Quarter 2017 Financial Results

IDHIFA® Approval for IDH2m R/R AML Validates Precision Medicine Approach; Ivosidenib NDA Submission for ...

Dr. Frédéric Triebel Presented at the World Immunotherapy Congress 2017

SYDNEY, Australia, Oct. 31, 2017 (GLOBE NEWSWIRE) -- Prima BioMed Ltd (ASX:PRR) (NASDAQ:PBMD) (“Prima”) ...

Dr. Frédéric Triebel Presented at the World Immunotherapy Congress 2017

SYDNEY, Australia, Oct. 31, 2017 (GLOBE NEWSWIRE) -- Prima BioMed Ltd (ASX:PRR) (NASDAQ:PBMD) (“Prima”) ...

Kura Oncology to Report Third Quarter 2017 Financial Results

SAN DIEGO, Oct. 31, 2017 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (NASDAQ:KURA), a clinical-stage ...